Bydureon exenatide once weekly: Phase III started

Amylin began the open-label, international Phase III DURATION-6 trial to compare Bydureon exenatide once weekly vs. once-daily Victoza liraglutide in 900 patients. Amylin and Eli Lilly co-developed Bydureon, which uses drug delivery technology from Alkermes. ...